Pfizer will face a class action lawsuit by investors who claim that the drugmaker’s Wyeth unit failed to disclose information about its antidepressant Pristiq’s negative effects on the heart and liver. Two pension funds claim that Pfizer’s Psubsequent disclosure of the drug’s negative effects caused the company’s stock to drop.
Article → Related Stories:
Pfizer’s Wyeth ordered to face class-action over Pristiq (Yahoo)
Pfizer’s Wyeth ordered to face class-action over Pristiq (Reuters)